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Abstract: The present study aimed to evaluate effects of a water-soluble protein fraction of 
chicken (CP), with a low methionine/glycine ratio, on plasma homocysteine and metabolites 
related to homocysteine metabolism. Male Wistar rats were fed either a control diet with 
20% w/w casein as the protein source, or an experimental diet where 6, 14 or 20% w/w  
of the casein was replaced with the same amount of CP for four weeks. Rats fed CP  
had reduced plasma total homocysteine level and markedly increased levels of the choline 
pathway metabolites betaine, dimethylglycine, sarcosine, glycine and serine, as well as  
the transsulfuration pathway metabolites cystathionine and cysteine. Hepatic mRNA  
level of enzymes involved in homocysteine remethylation, methionine synthase and  
betaine-homocysteine S-methyltransferase, were unchanged, whereas cystathionine  
gamma-lyase of the transsulfuration pathway was increased in the CP treated rats. Plasma 
concentrations of vitamin B2, folate, cobalamin, and the B-6 catabolite pyridoxic acid were 
increased in the 20% CP-treated rats. In conclusion, the CP diet was associated with lower 
plasma homocysteine concentration and higher levels of serine, choline oxidation and 
transsulfuration metabolites compared to a casein diet. The status of related B-vitamins was 
also affected by CP. 
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1. Introduction 
Hypolipidemic effects of processed proteins or peptides have been reported in numerous different 
animal models [1–7]. These effects are most likely due to the amino acid composition or specific peptides 
in the different protein sources [1,8–10]. Recently, we have shown that a water-soluble protein extract 
of chicken (CP) had both hypotriglyceridemic and hypocholesterolemic effects in male Wistar rats [11]. 
The triglyceride lowering effect of the CP extract was associated with reduced hepatic triglyceride 
synthesis and increased mitochondrial oxidation of fatty acids, perhaps mediated by peroxisome 
proliferator-activated receptor (PPAR) α, of which the gene expression was increased. We also observed 
different plasma concentrations of several amino acids between the groups, with lower methionine and 
higher glycine and serine in animals fed CP. 
Methionine serve as the precursor of the universal methyl donor S-adenosylmethionine (SAM), used 
in numerous methylation reactions throughout the body, with homocysteine (Hcy) being the end  
product [12]. The total amount of circulating homocysteine is referred to as total homocysteine (tHcy), 
and like the well-known lipid parameters, elevated circulating tHcy is also linked to increased risk of 
cardiovascular disease [13], though a causal relationship has been questioned due to the absence of 
clinical benefit after Hcy-lowering B-vitamin therapy [14]. Hcy has two metabolic fates. First, it can be 
permanently eliminated via the transsulfuration pathway to cystathionine and cysteine by the  
B6-dependent cystathionine beta-synthase (CBS) and cystathionine gamma lyase (CTH). Secondly, Hcy 
can be remethylated back to methionine either by methionine synthase (MS), which utilizes  
5-methyltetrahydrofolate (mTHF) and cobalamin as cofactors, or by betaine-Hcy S-methyltransferase 
(BHMT), using betaine as the methyl donor [12]. BHMT-mediated remethylation of Hcy is linked to the 
choline oxidation pathway. In this reaction, betaine is converted to dimethylglycine (DMG), and further 
catabolized to sarcosine and glycine by the B2-dependent DMG dehydrogenase (DMGDH) and 
sarcosine dehydrogenase (SARDH), respectively [15,16]. Sarcosine can also be formed from glycine by 
the cytosolic enzyme glycine methyltransferase (GNMT), using SAM as methyl donor [17], and this is 
thought to modulate SAM levels by metabolizing excess SAM [18]. The interconversion between 
glycine and serine is provided by serine hydroxymethyltransferase (SHMT) [19]. The Hcy metabolism 
and the choline oxidation pathway are depicted in Figure 1. 
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Figure 1. Overview of the homocysteine metabolism and the choline oxidation pathway. 
Homocysteine is catabolized through the transsulfuration pathway, or remethylated to 
methionine through either methionine synthase or betaine-homocysteine methyltransferase. 
The latter connects homocysteine metabolism to the choline oxidation pathway.  
BADH, betaine aldehyde dehydrogenase; BHMT, betaine homocysteine methyltransferase; 
CBS, cystathionine beta-synthase; CH3-X, methylated methyl acceptor; CHDH, choline 
dehydrogenase; CTH, cystathionine gamma lyase; CTP, cytidine triphosphate; DMG, 
dimethylglycine; DMGDH, dimethylglycine dehydrogenase; Hcy, homocysteine; Met, 
methionine; MTs, methyltransferases; MTR, methionine synthase; PC, phosphatidylcholine; 
PE, phosphatidylethanolamine; PEMT, phosphatidylethanolamine methyltransferase;  
SAH, S-adenosylhomocysteine; SAHH, S-adenosylhomocysteine hydrolase; SAM,  
S-adenosylmethionine; SARDH, sarcosine dehydrogenase; SHMT1, cytosolic serine 
hydroxymethyltransferase; SHMT2, mitochondrial serine hydroxymethyltransferase; THF, 
tetrahydrofolate; X, methyl acceptor. 
The aim of the present study was to provide further insight into effects of a water-soluble  
protein extract of chicken with particular emphasis on diet related changes in Hcy metabolism.  
Thus, we measured the effects of the protein source on one-carbon metabolites and vitamin B status in 
plasma, as well as changes in hepatic gene expression. The results show substantial protein-induced 
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2. Materials and Methods 
2.1. Animals and Diets 
Male Wistar rats (Tactonic Europe A/S, Ry, Denmark) 12 weeks old, were housed in Makrolon type 
II cages, 3 animals per cage, in an open system. They were kept under standard laboratory conditions 
with temperature 22 ± 1 °C, dark/light cycles of 12/12 h, relative humidity 55% ± 5% and 20 air changes 
per hour. The animal study was conducted according to the Guidelines for the Care and Use of 
Experimental Animals, and the Norwegian State Board of Biological Experiments with Living Animals 
approved the protocol. 
Animals were divided at random into 4 groups of 6 rats, and after 7 days of acclimatization, the control 
group were fed a 20% casein diet with 7% fat (5% lard and 2% soy oil) while in the intervention diets, 
casein was replaced with 6%, 14% or 20% CP (group 2–4), respectively. The composition of the diets, the 
procedures of making the water soluble CP extract and the amino acid profile of casein and CP are 
previously described [11], and the amino acid composition is given in Table 1. Notably, the 20% CP diet 
contains only half the amount of methionine, and has a 6-fold higher content of glycine compared to the 
casein diet, resulting in a 14-fold lower ratio of methionine to glycine. This resulted in a 57-fold lower 
ratio in plasma [11]. All groups had free access to tap water and feed during the  
28 days experiment. Rat feed intake and weight gain were determined twice a week. Rats in the 20% CP 
group had a higher feed intake as compared to control, but gained less weight [11]. 
Table 1. Amino acid composition of the control diet and the 20% CP diet. 
Amino Acid (mg/kg) Control 20% CP 
Ala 6.37 11.79 
Arg 5.77 9.98 
Asx 15.87 11.58 
Glx 49.44 22.11 
Gly 3.65 22.67 
His 5.39 3.20 
Hyp 0 11.86 
Ile 11.20 4.11 
Leu 19.65 8.49 
Lys 17.15 7.69 
Met 5.73 2.60 
Phe 10.32 5.01 
Pro 23.46 15.04 
Ser 11.07 5.68 
Tau 0.01 0.64 
Thr 9.15 4.71 
Tyr 8.24 2.34 
Val 13.47 5.41 
Ala, alanine; Arg, arginine; Asx, aspartic acid + aspargine; Glx, glutamic acid + glutamine; Gly, glycine;  
His, histidine; Hyp, hydroxyproline; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, 
phenylalanine; Pro, proline; Ser, serine; Tau, taurine; Thr, threonine. 
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All rats were killed on day 28 after an overnight fast. They were anesthetized by inhalation of 2% 
Isofluorane (Forane, from Abbott Laboratories Ltd, Chicago, IL, USA) in an anesthesia chamber and 
thoracotomy, cardiac puncture, and exsanguination was performed. Plasma and liver samples were 
stored at −80 °C. 
2.2. Biochemical Analyses 
Methylmalonic acid (MMA), tHcy, sarcosine, serine and glycine were analyzed in plasma by gas 
chromatography- tandem mass spectrometry (GC-MS/MS) [20]. Plasma choline, betaine, DMG, 
methionine, cysteine, and creatinine, [21], and all vitamin B2, B3, and B6 forms (flavin mononucleotide 
(FMN), riboflavin, nicotinamide, N1-methylnicotinamide, pyridoxal phosphate (PLP), pyridoxal  
and pyridoxic acid) and cystathionine [22] were analyzed by liquid chromatography-tandem  
mass spectrometry (LC-MS/MS). Plasma folate and cobalamin were measured by microbiological 
assays [23,24]. All analyzes were performed at Bevital A/S (http://www.bevital.no; Bergen, Norway) 
2.3. Gene Expression Analysis 
Gene expression analyses were performed in the control group and the 20% CP group.  
Total cellular RNA was purified from 20 μg of frozen liver samples using the RNeasy Mini Kit (Qiagen, 
Hilden, Germany). The quantity of the RNA was measured spectrophotometrically using a NanoDrop 
1000 (NanoDrop Products, Wilmington, DE, USA) and the quality of the RNA was analyzed using the 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). The Applied Biosystems High 
Capacity cDNA Reverse Transcription Kit with RNase inhibitor (Foster City, CA, USA) was used to 
obtain cDNA by reverse transcription of 1 µg RNA. Real-time PCR was performed in triplicates with 
Sarstedt 384 well multiply-PCR Plates (Sarstedt Inc., Newton, NC, USA) on the following genes, using 
probes and primers from Applied Biosystems: choline kinase alpha (Chka, Rn00567492_m1), choline 
kinase beta (Chkb, Rn01407345_m1), phosphatidylethanolamine N-methyltransferase (Pemt, 
Rn00564517_m1), choline dehydrogenase (Chdh, Rn01644299_m1), Bhmt (Rn00578255_m1), Dmgdh 
(Rn00594751), Sardh (Rn00454657_m1), Shmt1, soluble (Rn01751636_m1), Shmt2, mitochondria 
(Rn01768052_m1), Gnmt (Rn00567215_m1), Mtr (5-methyltetrahydrofolate-homocysteine 
methyltransferase, Rn00578368_m1), methyltetrahydrofolate-homocysteine methyltransferase 
reductase (Mtrr, Rn01409369m1), Cbs (Rn00560948_m1) and Cth (Rn00567128_m1). 
Three different reference genes were included: 18s (Kit-FAM-TAMRA (Reference RT-CKFT-18s)) 
from Eurogentec, Belgium, glyceraldehyde-3-phosphate dehydrogenase (Gapdh, Taqman Rodent 
GAPDH, No. 4308313) and ribosomal protein, large, P0 (Rplp0, Rn00821065_g1) from Applied 
Biosystems. cDNA was generated from universal rat reference RNA (Agilent Technologies) and used 
in 5–6 serial dilutions as a standard curve in all gene runs. The NormFinder software was used to evaluate 
the reference genes [25], and data were normalized to 18 s. Finally, expression values relative to the 
control group were calculated by dividing all individual values with the control group mean, and the 
results are presented as relative values ± SDs. 
  
 
Nutrients 2015, 7 4503 
 
2.4. Statistical Analysis 
Data sets were analyzed using Prism Software (Graph-Pad Software, San Diego, CA, USA) to 
determine statistical significance. The results are shown as means of 6 animals per group with their 
standard deviations. For the metabolite analyses, between-group differences were tested by one way 
ANOVA, and Dunnet’s post hoc test was performed to evaluate statistical differences between the 
individual intervention groups toward the control group. For the gene expression analyses, normal 
distribution was determined by the Kolmogorov-Smirnov test (with Dallal-Wilkinson-Lilliefor  
p value), and p-values < 0.05 were considered not normally distributed. Unpaired t-test was performed 
to evaluate statistical differences between groups, or Mann Whitney test when values were not normally 
distributed. p-Values < 0.05 were considered significant. 
3. Results 
3.1. Metabolites 
The plasma levels of methionine (Figure 2A) was reduced, and tHcy (Figure 2B) was lowered by CP. 
Metabolites of the transsulfuration pathway were also affected by CP treatment as the plasma 
concentrations of both cystathionine (Figure 2C) and cysteine (Figure 2D) were increased by 14% and 
20% CP. In addition, CP increased the creatinine level in a dose-dependent manner (Figure 2E). 
 
Figure 2. Plasma concentration of metabolites related to homocysteine metabolism. Rats 
were fed a 20% (w/w) casein control diet, or a diet containing 6%, 14% or 20% chicken 
protein (CP) for 4 weeks. Methionine (A), homocysteine (B), cysteine (C), cystathionine 
(D), and creatinine (E), were measured in fasting plasma samples. Values shown are means 
± standard deviation (n = 6). One-way ANOVA with Dunnet’s post hoc test was used to 
determine values significantly different from control (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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No change in plasma choline was observed in rats fed CP compared to controls (Figure 3A). The 
plasma concentrations of betaine (Figure 3B), DMG (Figure 3C), sarcosine (Figure 3D), glycine (Figure 
3E), and serine (Figure 3F) were increased in the CP-treated rats compared to casein-fed rats. 
 
Figure 3. Plasma concentration of metabolites of the choline oxidation pathway. Rats were 
fed a 20% (w/w) casein control diet, or a diet containing 6%, 14% or 20% chicken protein 
(CP) for 4 weeks. Choline (A), betaine (B), dimethylglycine (DMG, C), sarcosine (D), 
glycine (E), and serine (F), were measured in fasting plasma samples. Values shown are 
means ± standard deviation (n = 6). One-way ANOVA with Dunnet’s post hoc test was used 
to determine values significantly different from control (* p < 0.05, ** p < 0.01,  
*** p < 0.001). 
3.2. Hepatic Gene Expression 
The hepatic mRNA level of Mtr was unchanged, while Mtrr showed a small but significant increase 
in expression. The hepatic gene expression of Cth, the final enzyme in the transsulfuration pathway, was 
significantly increased 1.4 fold after CP administration. However, the mRNA level of the first enzyme 
in this pathway, Cbs, was unchanged. 
The gene expression of Pemt was unchanged. The hepatic mRNA level of the gene encoding Chka, 
Chkb and of genes involved in the choline oxidation pathway, Chdh, Bhmt, Dmgdh, Sardh and Gnmt, 
were all unchanged in the CP-treated animals. The expression of genes involved in serine and glycine 
interconversion, Shmt1 and Shmt2, however, was significantly increased (Table 2). 
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Table 2. Hepatic gene expression after 4 weeks of dietary intervention1. 
Gene Diet Groups  
Symbol Name Control Chicken Protein p-Value 
Homocysteine Remethylation   
Mtr 
Methionine synthase  
(5-methyltetrahydrofolate-homocysteine 
methyltransferase) 
1.00 ± 0.19 0.98 ± 0.23 0.856 
Mtrr 
Methionine synthase reductase  
(5-methyltetrahydrofolate-homocystein ) 
1.00 ± 0.03 1.11 ± 0.07 0.005 
Transsulfuration   
Cbs Cystathionine-beta-synthase 1.00 ± 0.25 0.94 ± 0.26 0.663 
Cth 
Cystathionase (cystathionine gamma 
lyase) Cse, Cys3 
1.00 ± 0.14 1.41 ± 0.24 0.005 




1.00 ± 0.14 1.14 ± 0.12 0.095 
Chka Choline kinase (alpha) 1.00 ± 0.21 0.82 ± 0.15 0.119 
Chkb 
Ethanolamine kinase/ 
Choline kinase beta 
1.00 ± 0.14 1.17 ± 0.16 0.084 
Choline Oxidation Pathway, Mitochondria  
Chdh Choline dehydrogenase 1.00 ± 0.10 1.01 ± 0.10 0.899 
Dmgdh Dimethylglycine dehydrogenase 1.00 ± 0.29 0.87 ± 0.19 0.377 
Sardh Sarcosine dehydrogenase 1.00 ± 0.11 1.18 ± 0.30 0.212 
Shmt2 Serine hydroxymethyltransferase 2 (mit) 1.00 ± 0.08 1.49 ± 0.25 0.001 




1.00 ± 0.34 0.76 ± 0.11 0.139 




1.00 ± 0.14 1.33 ± 0.14 0.002 
1 Expression levels were normalized to 18 s expression and relative values to control are given as means ± SD 
(n = 6). Results were analyzed by unpaired t-test or by Mann Whitney test if not normally distributed according 
to the Kolmogorov-Smirnov test of normality. p < 0.05, significantly different from control values. 
3.3. Vitamin B Status 
The plasma concentration of flavin mononucleotide (FMN) and riboflavin was significantly increased 
in rats fed the 20% CP diet compared to control (Figure 4A,B). The plasma concentration of PLP and 
pyridoxal was unchanged in CP-fed rats compared to control (Figure 4C,D). However, an increased 
plasma level of pyridoxic acid was observed in the 20% CP group (Figure 4E). Plasma levels of folate 
were increased in all CP-fed rats (Figure 4F) while cobalamin was increased only by the 20% CP  
(Figure 4G). In contrast, the functional marker of vitamin B12, MMA, was unchanged (Figure 4H). 
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Figure 4. Plasma concentrations of markers of B-vitamin status. Rats were fed a 20% (w/w) 
casein control diet, or a diet containing 6%, 14% or 20% chicken protein (CP) for 4 weeks. 
Flavin mononucleotide (FMN, A), riboflavin (B), pyridoxal phosphate (PLP) (C), pyridoxal 
(D), pyridoxic acid (E), folate (F), cobalamin (G), and methylmalonic acid (MMA, H), were 
measured in fasting plasma samples. Values shown are means ± standard deviation (n = 6). 
One-way ANOVA with Dunnet’s post hoc test was used to determine values significantly 
different from control (* p < 0.05, ** p < 0.01, *** p < 0.001). 
4. Discussion 
In this study in rats fed a normal fat diet (7%, w/w) we demonstrated that a water-soluble protein 
extract of chicken (CP) with a low methionine/glycine ratio reduced plasma tHcy and increased levels 
of serine and metabolites of choline oxidation and transsulfuration compared to a casein diet. The CP 
diet also affected the status of several B vitamins. 
Hcy is produced from methionine during a myriad of methylation reactions, and early experiments 
demonstrated that curtailed dietary supply of labile methyl groups like methionine and choline, increases 
the rate of Hcy remethylation back to methionine [26]. Additionally, excess methionine intake has been 
shown to decrease remethylation of Hcy [27]. Finally, a low methionine-glycine ratio, as in CP compared 
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to casein (0.11 vs. 1.57, respectively [11]), has previously been suggested to lower tHcy in rats [1]. 
Together, this suggests the substantially lower content of methionine in the CP diet to be an important 
determinant of the lower tHcy observed among the CP fed rats. A probable increase in BHMT activity, 
a known effect following reduced methionine intake [28], would also help explain the higher 
concentrations of DMG and sarcosine after CP treatment. Additionally, according to the USDA food 
composition database (http://ndb.nal.usda.gov), the betaine content of chicken meat from legs and wings 
is about twice as high as compared to dairy products. This could explain the higher plasma concentration 
of betaine, and also supports increased BHMT-mediated remethylation of Hcy, leading to increased 
production of the downstream metabolites DMG and sarcosine. However, the gene expression of  
BHMT was similar between groups, indicating that a potential altered activity must be related to  
post-transcriptional regulation. 
Although gene expression of MS was unchanged, an increased remethylation by this enzyme cannot 
be excluded. The CP fed rats showed higher plasma folate compared to control which is associated with 
lower tHcy levels in humans [29,30], as well as in mouse models [31], generally believed to be mainly 
related to mTHF being the methyl donor for MS-mediated remethylation of homocysteine. However, 
reduced Hcy production due to mTHF being an inhibitor of methyltransferases like GNMT [18] seems to 
be the most important mechanism for this association, as demonstrated in subjects with marginal folate 
status [32]. We also observed higher levels of vitamin B2, which could increase enzyme activity of 
important enzymes in the folate cycle, including methylene tetrahydrofolate reductase, responsible for 
mTHF production, and MS reductase, important for maintaining MS function [33,34]. This would support 
increased production of mTHF, thus contributing to the Hcy-lowering. 
Importantly, the tHcy decrease could also be the consequence of increased Hcy catabolism through 
the transsulfuration pathway, as the gene expression of Cth was significantly increased. This was 
accompanied by increased plasma concentrations of cystathionine and cysteine. However, when dietary 
supply of methionine is low, previous studies have shown that transsulfuration flux decreases [35]. 
Additionally, CTH mRNA changes were small and may not alter its protein expression. 
The concentrations of other metabolites along the choline oxidation pathway, namely DMG, 
sarcosine, glycine and serine were increased after CP administration. The gene expression of Bhmt, 
Dmgdh and Sardh was unchanged after CP treatment. Notably, the 20% CP diet contained six-fold 
higher levels of glycine, while the content of serine was only half compared with the control diet [11]. 
Thus, we cannot rule out the possibility that the increased level of plasma DMG and sarcosine could be 
a direct consequence of product inhibition of SARDH and DMGDH, respectively, due to the higher 
intake of glycine in the CP fed animals. Glycine is also a product of the catabolism of threonine [36], 
but as the threonine content of CP was much lower than in casein, this was most probably not  
a significant contributor to the elevated plasma glycine. Serine is used as a substrate for the first  
enzyme in the transsulfuration pathway, where serine and Hcy condenses to form cystathionine.  
If transsulfuration flux is reduced to spare Hcy for methionine synthesis, this could contribute to the 
accumulation of serine. However, an increased expression of Shmt1 and Shmt2 mRNA was observed, 
which suggest that the higher concentrations of serine observed among the animals receiving the CP diet 
may also be due to increased conversion from glycine. We observed increased catabolism of vitamin B6, 
which is used for degradation of glycine through the glycine cleavage system in the mitochondria [37]. 
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Thus, further studies should evaluate if increased B6 catabolism is a mechanism induced to spare glycine 
for serine production. 
5. Conclusions 
In summary, a water-soluble protein extract of chicken (CP) reduced plasma tHcy and interfered with 
circulating markers of B vitamin status. The low ratio of methionine to glycine in CP may play an 
important role due to the importance of regulating methionine availability for methylation reactions, and 
the higher folate concentrations may have contributed to decreased Hcy synthesis due to its ability to 
inhibit methyltransferases like GNMT. Further studies are needed to further clarify the specific effects 
of individual dietary amino acids or different amino acid composition on the metabolic pathways related 
to Hcy metabolism. 
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